Polygenic risk scores are proving to be a powerful tool in the era of genomic medicine.
Their application has grown substantially – from predicting common diseases to
enhancing risk modelling for various types of cancers. What does this mean for insurers?
Article: https://www.swissre.com/reinsurance/life-and-health/l-h-risk-trends/polygenic-risk-scores-better-cancer-predictor-for-insurers
Interesting article, an oldie but very readable for GTG holders..
.
Polygenic risk scores: a better cancer predictor for insurers?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable